With Bharat Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from With bharat biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In With Bharat Biotech Today - Breaking & Trending Today

Do Kids Need Covid Vaccines, What Are The Side Effects And Precautions, Know From Expert

Do Kids Need Covid Vaccines, What Are The Side Effects And Precautions, Know From Expert
Outlook got in touch with Dr. Prabhat Maheshwari, Chief- Neonatal & Paediatric Critical Care, Artemis Hospitals Gurgaon to answer all your questions:
Dr. Prabhat Maheshwari
17 May 2021, Last Updated at 7:30 am
File photo
Dr. Prabhat Maheshwari
2021-05-17T07:25:02+05:30
Do Kids Need Covid Vaccines, What Are The Side Effects And Precautions, Know From Expert
outlookindia.com
2021-05-17T07:30:29+05:30
Also read
With Bharat Biotech’s inactivated virus-based Covid-19 vaccine Covaxin now set for phase 2 and 3 clinical trials on children in the 2-12 years age group, the stage is set for a pediatric range to hit the market. Experts believe this is a critical step to ensure a break in transmission. ....

Prabhat Maheshwari , Zydus Cadila Zyco , Krishna Ella , Indian Council Of Medical Research , Meditrina Institute Of Medical Sciences , With Bharat Biotech , Zydus Cadila , Biotech Chairman , Managing Director Krishna Ella , Paediatric Critical Care , Artemis Hospitals Gurgaon , Bharat Biotech , Indian Council , Medical Research , Controller General , Meditrina Institute , Medical Sciences , பிரபத் மகேஸ்வரி , கிருஷ்ணா எல்லா , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , மேதிற்றின நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , உடன் பாரத் பயோடெக் , ஜய்துச் காடிலா , பயோடெக் தலைவர் , நிர்வகித்தல் இயக்குனர் கிருஷ்ணா எல்லா , குழந்தை முக்கியமான பராமரிப்பு ,

Bharat Biotech trial nod a turning point for paediatric Covid-19 vaccine

Experts believe this is a critical step to ensure break in transmission.
Apart from Covaxin, two more vaccine candidates would be available for paediatric use in India. Zydus Cadila’s ZyCoV-D has been tested on children above 12 years and on Monday the USFDA authorized use of Pfizer’s mRNA vaccine on kids as young as 12 years.
Bharat Biotech has already conducted trials on children 12 years and above. Bharat Biotech Chairman and Managing Director Krishna Ella had said last year: “Our vaccine is safe, and built on time-tested and proven technology. It can be given to a six-month-old or a 60-year-old.” ....

Tamil Nadu , Zydus Cadila , Zydus Cadila Zyco , Krishna Ella , T Jacob John , Sharvil Patel , Christian Medical College , With Bharat Biotech , Biotech Chairman , Managing Director Krishna Ella , Jacob John , Cadila Healthcare , Corona Virus , Covid 19 , Bharat Biotech , Health Ministry , Child Vaccination , Nder 18 Vaccine , தமிழ் நாடு , ஜய்துச் காடிலா , கிருஷ்ணா எல்லா , டி ஜாகோப் ஜான் , ஷார்வில் படேல் , கிறிஸ்துவர் மருத்துவ கல்லூரி , உடன் பாரத் பயோடெக் , பயோடெக் தலைவர் ,

Covaxin exceeds efficacy of most traditional platform-based COVID-19 vaccines

Covaxin exceeds efficacy of most traditional platform-based COVID-19 vaccines
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy
PB Jayakumar | March 3, 2021 | Updated 23:04 IST
With Bharat Biotech announcing 81 per cent interm efficacy for India s first indigeneously developed coronavirus vaccine Covaxin, India has joined the league of front runners across the globe who have developed the most efficient vaccines for this pandemic.
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy. The Pfizer vaccine showed efficacy of 95 per cent at preventing symptomatic COVID infection after two doses and the Moderna vaccine is 94.1 per cent effective after the second dose. However, this vaccine s efficacy was seen slightly lower in people above 65 years. These vaccin ....

United States , South Africa , Zydus Cadila , Sinovac Coronavac , Astrazeneca Oxford University , Drug Administration , India Serum Institute Of , With Bharat Biotech , Serum Institute , South America , Covaxin Efficacy , Bharat Biotech Covaxin , Covaxin Vaccine , Covaxin Bharat Biotech , Bharat Biotech Covaxin Efficacy , Covaxin Vaccine Bharat Biotech , Covaxin In Bharat Biotech , Covaxin Coronavirus Vaccine , Covaxin Efficacy Data , Covaxin 81 Efficacy , ஒன்றுபட்டது மாநிலங்களில் , ஜய்துச் காடிலா , இந்தியா சீரம் நிறுவனம் ஆஃப் , உடன் பாரத் பயோடெக் , சீரம் நிறுவனம் , தெற்கு அமெரிக்கா ,